Cambridge Cognition announced the use of its ‘CANTAB’ cognitive assessment product in two phase three clinical trials conducted by Bristol Myers Squibb for ‘Cobenfy’, a newly FDA-approved treatment ...

Drugs for metabolic diseases, vaccines, and cancer therapies feature among new product launches this year that could top $1 billion in annual sales or be clinical "game changers" in the next five ...

NEW YORK, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative ...

Blarcamesine: Potential novel oral treatment to target upstream Alzheimer’s disease pathology through autophagy enhancementSubmission based on ...

For bladder control, these medications block the muscarinic M3 receptors on the smooth muscles of the bladder to prevent contractions ... Tofranil belongs to a class of medications called tricyclic ...

A literature review was performed to collect information on the role of pharmacogenetics in six proposed teratogenic mechanisms associated ... and angiotensin II receptor antagonism ...

In this special issue of Research Topic, authors focus on the significance of non-neuronal acetylcholine (NNA) in the cardiovascular system under different physiological and pathological conditions ...

What I like the most about this new treatment is its mechanism of action, which leverages CRF1 receptor antagonism. This is why management appears relatively confident about its global sales ...

At present no definitive medical treatment exists for acute pancreatitis. [9,10] Pirenzepine has shown encouraging positive responses and a low incidence of adverse effects when used to treat ...

Recent advancements in understanding the molecular basis of the prostaglandin D2 receptor (DP2) have significant implications for developing new anti-inflammatory and anti-allergic therapeutics.

A protein called the androgen receptor normally functions to guide the development of the prostate—signaling the cells to stop growing, act as normal prostate cells and maintain a healthy state.